Mission Pharmacal

Executive Summary

Mission Pharmacal is a privately held, diversified pharmaceutical company headquartered in San Antonio, Texas, with a legacy spanning over 75 years. The company operates through three core segments: branded pharmaceuticals and over-the-counter (OTC) products, generic pharmaceuticals, and contract development and manufacturing (CDMO). Mission Pharmacal has established leadership positions in women's health, urology, and dermatology, leveraging its expertise to identify and address unmet medical needs. With a focus on high-quality products and a robust manufacturing capability, the company serves as a reliable partner for both branded and generic drug development, as well as a CDMO provider for external clients. Its long-standing history and diversified business model position it for steady growth in the pharmaceutical landscape, though its private status limits visibility into specific financial and pipeline details.

Upcoming Catalysts (preview)

• Q2 2026FDA approval of a new branded product in women's health or urology70% success
• 2026Expansion of CDMO capacity through a new facility or partnership80% success
• Q3 2026Launch of a high-value generic product in dermatology65% success